IMBDX

IMBDX EBITDA per Share

The EBITDA per Share of IMBDX (461030.KQ) as of Oct 27, 2026 is -618.09 KRW. In the previous year, EBITDA per Share was -667.05 KRW — a change of -7.34% (higher).

EBITDA per Share

-618.09KRW

YoY

-7.34%

Last updated:

EBITDA per Share of IMBDX is 2025 -618.09 KRW. EBITDA per Share of IMBDX was 2024 -667.05 KRW. It decreases by -7.34% higher compared to the previous year.

The IMBDX EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
-646.08 KRW
Jan 1, 2022
-591.82 KRW
Jan 1, 2023
-525.61 KRW
Jan 1, 2024
-667.05 KRW
Jan 1, 2025
-618.09 KRW
The IMBDX EBITDA per Share history
YEAREBITDA per ShareYoY
-618.09KRW-7.34%
-667.05KRW+26.91%
-525.61KRW-11.19%
-591.82KRW-8.40%
-646.08KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IMBDX Stock analysis

What does IMBDX do? IMBDX Inc provides laboratory analysis services including clinical diagnosis and genetic analysis using liquid biopsy technology. The company develops, manufactures, and sells diagnostic products alongside its service offerings. Its primary customers are healthcare providers and medical institutions requiring advanced diagnostic solutions. The firm generates revenue through service fees for laboratory analyses and sales of diagnostic products. The company's service portfolio focuses on clinical diagnosis services and genetic analysis services based on liquid biopsy technology. Diagnostic product sales contribute to its revenue stream alongside service-based income. Healthcare institutions and medical facilities represent the key customer segment purchasing these services and products. IMBDX Inc's business model combines service delivery with product sales in the medical diagnostics sector. Revenue is derived from both recurring laboratory analysis service contracts and one-time diagnostic product purchases. The company targets healthcare providers seeking innovative diagnostic technologies for patient care. IMBDX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IMBDX stock

EBITDA per Share of IMBDX is -618.09 KRW in 2025.

EBITDA per Share of IMBDX changed from -667.05 KRW to -618.09 KRW, representing a -7.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share IMBDX since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — IMBDX

All Key Metrics — IMBDX